WEC
VSTM icon

Winslow Evans & Crocker’s Verastem VSTM Stock Holding History

Winslow Evans & Crocker’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-79
Closed -$2K – 1165
2020
Q2 		$2K Hold
79
– – ﹤0.01% 1057
2020
Q1 		$4K Buy
+79
New +$1.98K ﹤0.01% 948

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Winslow Evans & Crocker's VSTM Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of Verastem (VSTM) in Q3 2020, closing a stake of 79 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in VSTM in Q1 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2020. 122 funds tracked by Wall St. Rank hold VSTM as of Q3 2020.

  • Winslow Evans & Crocker reported no remaining Verastem position as of Q3 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 79 Verastem shares in Q3 2020, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in Verastem in Q1 2020 and held it in 2 quarters.
  • Winslow Evans & Crocker's Verastem position peaked at $4K in Q1 2020.
  • 122 funds tracked by Wall St. Rank held Verastem as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.